Dr. Siobhan S. Proksell, MD

Dr. Proksell practices at UCHealth University of Colorado Hospital in Aurora, Colorado, part of UCHealth.

Dr. Proksell's NPI, 1184990079, was assigned on March 26, 2012. Dr. Proksell graduated from University of Miami, Lm Miller School of Medicine in 2012. Dr. Proksell holds Florida license ME147737.

Dr. Proksell's primary practice is UCHealth University of Colorado Hospital, at 12605 E 16th Ave, Aurora, CO 80045 in Adams County. The practice phone is (720) 848-0000.

Dr. Proksell's primary practice is UCHealth University of Colorado Hospital in Aurora, Colorado, part of UCHealth. Dr. Proksell is also affiliated with Sylvester Comprehensive Cancer Center. The medical group on file is University of Colorado Medicine (CU Medicine). Dmand AI also links Dr. Proksell to 3 more hospitals, 2 group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Proksell practices, 7 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Dr. Proksell's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dmand AI has Dr. Proksell's licenses on file in 2 states: Florida and Pennsylvania.

CMS data shows 295 Medicare services from Dr. Proksell across 7 procedure codes in 2024, for 165 Medicare patients. Medicare paid $20,115 for them.

CMS counts 165 Medicare patients who saw Dr. Proksell in 2024. The largest group is 65 to 74, with 76 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 29% are also on Medicaid. Their average risk score is 2.75, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Proksell's median patient age at 56, with 58% women.

In 2024, Dr. Proksell wrote 387 Medicare Part D claims for 91 patients. 46% of them were for generic drugs. CMS names the drug for 260 of them, across 10 drugs with 11 or more claims each, at $2,294,057 in total drug cost. In 2023, CMS named 224 claims across 9 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Dr. Proksell for performance year 2024, reported as part of a group. Dr. Proksell accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Proksell as offering telehealth. CMS counts 61 procedures of colonoscopy by Dr. Proksell, more than 68% of the clinicians it reports for that procedure.

Dmand AI links 20 papers to Dr. Proksell, published from 2013 to 2025. 2024 was the busiest year, with 5. The most frequent topics are Crohn Disease, Inflammatory Bowel Diseases and Colitis, Ulcerative. Dr. Proksell has published most often in Inflamm Bowel Dis. Dr. Proksell's most frequent co-authors are Maria Teresa Abreu, MD, Oriana Mazorra Damas, MD and Amar R. Deshpande, MD.

CMS Open Payments shows 28 general payments to Dr. Proksell from 14 drug and device companies from 2017 to 2025. Food and beverage make up the largest share, 92% of the total. Takeda Pharmaceuticals U.S.A., Inc. paid the most, $446.

Dr. Proksell graduated from University of Miami, Lm Miller School of Medicine in 2012.